A growing body of preclinical, imaging, and human observational data suggests that GLP-1 receptor agonists (GLP-1RAs) may meaningfully improve cerebral blood flow (CBF), a critical factor in maintaining cognitive function and minimizing dementia risk
Gastrointestinal side effects, including heartburn, are most likely when increasing your dose and often improve with time
Another common alkaloid that affects the nervous system is the nicotine commonly found in tobacco
To ensure data quality, all publications underwent evaluation for methodology, with the following variables being distinguished: authors, study design, study duration, year of publication, study population size, inclusion and exclusion criteria, and research findings